Carvedilol versus Propranolol in Preventing Decompensation in Patients with Compensated Cirrhosis: A Real-World Propensity-Matched Study
In this real-world study, carvedilol demonstrated superior efficacy compared with propranolol in reducing key decompensatory events in patients with compensated cirrhosis, likely due to its enhanced ability to lower portal pressure. However, the mortality benefit probably requires further studies to unfold.
Authors
- Guneet Sidhu (ORCID: https://orcid.org/0000-0001-6107-9689)
- John Bassett
- Raza Malik (ORCID: https://orcid.org/0000-0003-4381-6053)
- Ming Lin (ORCID: https://orcid.org/0000-0002-4622-2886)
- Muhammad Ali Butt
- Nabeeha Mohy-Ud-Din
- Rahul Karna
- Himsikhar Khataniar
- Hussam Almasri
Institutions
- Sanford Health (US)
- Allegheny Health Network (US)
- Twin Cities Orthopedics (US)
- Lahey Medical Center (US)
- North Dakota State University (US)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2025-12-26
- DOI
- https://doi.org/10.15403/jgld-6497
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00